Fig. 1From: Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapiesIllustration of the preparation of PLTM-HMnO2@Bu NPs and in vivo MR iamging-monitored targeted chemo-chemodynamic combined therapy. Reproduced with permission from Ref. [81]. Copyright 2020, Elsevier Inc.Back to article page